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Abstract
The hexose transporter family, which mediates a facilitated uptake in mammalian cells, consists of more than 10 members containing 12
membrane-spanning segments with a single N-glycosylation site. However, it remains unknown how these isoforms are functionally
organized in the membrane domains. In this report, we describe a differential distribution of the glucose transporter isoforms GLUT1 and
GLUT3 to detergent-resistant membrane domains (DRMs) in non-polarized mammalian cells. Whereas more than 80% of cellular proteins
containing GLUT3 in HeLa cell lines was solubilized by a non-ionic detergent (either Triton X-100 or Lubrol WX) at 4 jC, GLUT1 remained
insoluble together with the DRM-associated proteins, such as caveolin-1 and intestinal alkaline phosphatase (IAP). These DRM-associated
proteins and the ganglioside GM1 were shown to float to the upper fractions when Triton X-100-solubilized cell extracts were centrifuged on
a density gradient. In contrast, GLUT3 as well as most soluble proteins remained in the lower layers. Furthermore, perturbations of DRMs
due to depletion of cholesterol by methyl-h-cyclodextrin (mhCD) rendered GLUT1 soluble in Triton X-100. Immunostaining patterns for
these isoforms detected by confocal laser scanning microscopy in a living cell were also distinctive. These results suggest that in non-
polarized mammalian cells, GLUT1 can be organized into a raft-like DRM domain but GLUT3 may distribute to fluid membrane domains.
This differential distribution may occur irrespective of the N-glycosylation state or cell type.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Hexose transporters represent a family of intrinsic mem-
brane proteins that mediate a facilitative uptake of hexose by
mammalian cells [1]. Previously, five functional isoforms
designated GLUT1–GLUT5 have been characterized [1]
and additional novel genes that encode hexose transporter-
like proteins GLUT6–GLUT11 have also been identified
[2]. Although the functional characterization of these new
members has not been completed, the members differ in
terms of tissue distribution, transport kinetics, and substrate
specificity. GLUT1 is distributed in many cells and its
increased expression is one of the most characteristic
changes associated with cell growth and malignant trans-
formation [3–6]. GLUT3 is also expressed in many tissues,
including brain, placenta and kidney [7], as well as in
several human tumors [8,9]. In contrast, GLUT2 and
GLUT4 as well as some novel glucose transporters
(GLUTs) show a tissue-specific distribution (GLUT2, liver
and pancreas; GLUT4, muscle and fat; GLUT8, blastocysts;
GLUT9, brain and leucocytes; GLUT11, heart and skeletal
muscle; etc.). GLUT5, which is expressed at highest levels
in the small intestine, was found to be a fructose transporter
[1]. Despite the high degree of sequence homology, each
isoform can be subject to distinct modes of regulation for
cellular localization and transport activity. For instance,
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GLUT1–3, GLUT5 and GLUT9 localize at the cell surface,
whereas GLUT4 or GLUT8 exhibits insulin-sensitive trans-
location from intracellular vesicles to the cell surface [1,
2,10].
We have recently investigated tumor-associated altera-
tions in glucose transporter expression in human cell hybrids
derived from cervical carcinoma HeLa cells and normal
fibroblasts [11–13], whose tumorigenicity may be controlled
by a putative tumor suppressor gene on chromosome 11 [14].
In these studies, we found that the tumor-suppressed hybrid
cells express GLUT1 alone, whereas tumorigenic cell hybrids
express both GLUT1 and GLUT3 as larger forms, probably
due to modifications of N-glycosylation [11–13]. However,
differences in the membrane distribution and roles of these
isoforms remain largely unknown.
GLUT1 and GLUT3 share many similarities in structure
and function; they have 12 membrane-spanning segments
with a single N-linked oligosaccharide chain on the outer
surface. About 65% of their amino acid sequence is homol-
ogous, but their C-terminal domains and the extracellular
loops are distinctive [1,7]. These isoforms have a high affinity
to D-glucose when expressed at the cell surface [15,16]. A
striking difference between them is reported in cellular local-
ization; in polarized epithelial cells, such as Caco-2 and
MDCK cells, GLUT1 is expressed on the basolateral surface,
while GLUT3 is sorted to the apical surface [17,18]. In
platelets and neuronal cells, GLUT3 is also present in intra-
cellular vesicles [19,20]. These results imply distinctive roles
for these transporters in mammalian cells.
Recent studies suggested that the plasma membrane in
mammalian cells is not homogeneously organized, contain-
ing specific microdomains, known as detergent-resistant
membranes (DRMs), lipid rafts or caveolae [21–26]. These
microdomains are enriched with cholesterol and sphingoli-
pids to organize an ordered lipid phase, including some
proteins such as caveolin, glycosylphosphatidyl-inositol
(GPI)-anchored proteins and Src-kinases. Mainly due to their
ordered lipid nature, these membrane domains are relatively
resistant to solubilization by non-ionic detergents. These
DRM domains are also functionally distinguishable, being
involved in various cellular events, such as signal trans-
duction and membrane trafficking [21–26]. The presence
of these microdomains under physiological conditions has
been shown with several procedures [26,27] and selective
pathways for sorting proteins through the trans-Golgi net-
work (TGN) to DRM domains or the polarized cell surface
are proposed in various cells [25]. In tumorigenic HeLa cell
hybrids, expression of caveolin-1 and intestinal alkaline
phosphatase (IAP), which may be components of the DRM,
was also modulated [28,29].
In the present study, we examined if there is any differ-
ential distribution of the glucose transporter isoforms in
regard to DRM domains in these cells. Here, we report for
the first time that GLUT1 distributes to a cholesterol-rich
DRMdomain, whereas GLUT3 localizes in a fluidmembrane
domain. The differential distribution of GLUT1 and GLUT3
may occur irrespective of the N-glycosylation state, the
tumorigenic state or cell type, implying that it is mainly due
to intrinsic properties.
2. Materials and methods
2.1. Chemicals
Rabbit polyclonal antibody against C-terminal peptides
of human GLUT1 and GLUT3 were purchased from Chem-
Fig. 1. Detergent-solubility of ceveolin-1, IAP, GLUT1 and GLUT3 in
human cell hybrids. HeLa cell hybrids, CGL4 cells, were solubilized by
either 1% or 0.5% Triton X-100 at 4 jC. Total cell lysate (T) was separated
into soluble (S) and insoluble (I) fractions by centrifugation at 12,000 g
for 30 min, and each sample (10 Ag protein/lane) was subjected to SDS-
PAGE, followed by Coomassie blue staining (A). The arrows indicate
proteins which were enriched (closed arrows) or reduced (open arrows) in
the insoluble fraction. (B) CGL4 cells were solubilized by 0.5% Triton
X-100, and subsequently fractionated samples (10 Ag protein/lane of T,
S, and I), prepared in (A), were similarly examined by SDS-PAGE and
immunoblotting for caveolin-1, IAP, GLUT1, GLUT3 and a-tubulin. The
corresponding molecular masses are indicated in kDa.
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icon (CA). Affinity-purified anti-GLUT3 rabbit polyclonal
antibody against C-terminal peptide was obtained from
MBL, Tokyo. Polyclonal antibodies against bovine IAP
(CALZYME, CA), human caveolin-1 (BD Transduction
Lab, KY), human transferrin receptor (CD71; Santa Cruz,
CA), and human clathrin HC (Santa Cruz) were used.
Mouse monoclonal antibody against a tubulin was pro-
vided by Sigma (MO). An enhanced chemiluminescence kit
(ECL) and [1a, 2a (n)-3H]cholesterol (1 mCi/ml) were
obtained from Amersham Pharmacia Biotech (Tokyo).
2.2. Cell culture
The human cell hybrids, CGL4 (tumorigenic) and CGL1
(non-tumorigenic), are subclonal derivatives of a parental
tumor-suppressed cell hybrid of HeLa D98/AH2 cells and
normal human fibroblasts [11]. These cell hybrids and a
human cervical carcinoma cell line, HeLa-S3, were grown
in Dulbecco’s modified Eagle’s medium (DMEM, GIBCO-
BRL) containing 5% fetal calf serum (FCS, MBL), pen-
icillin (100 U/ml) and streptomycin (100 Ag/ml) under
humidified 5% CO2/95% air at 37 jC, as described pre-
viously [11]. The GLUT3-transfectant which stably overex-
pressed GLUT3 in CGL4 cells (CGL4/Glut3) and CGL1
cells (CGL1/Glut3) were maintained in DMEM containing
G418 (600 Ag/ml), 5% FCS, penicillin and streptomycin
under 5% CO2 at 37 jC as described previously [13]. The
rabbit GLUT1 cDNA [16] in an expression vector (pME18
Sneo) was similarly transfected into CGL4 cells and a stable
clone, CGL4/Glut1, which overexpressed GLUT1 was iso-
lated and determined. These cells were free from myco-
plasma contamination.
2.3. Cell lysate and immunoblotting
Cell lysates in lysis buffer (150 mM NaCl, Tris–HCl, pH
7.4, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100 and 0.5%
NP-40) were prepared, as described previously [13], and the
Fig. 2. Detergent-insolubility of GLUT1 in cDNA-transfected HeLa cell hybrids or in different cell types. (A) Stable transfectants of CGL4 cells, which
overproduced GLUT3 (CGL4/Glut3), were solubilized by Triton X-100 (1% or 0.5%) at 4 jC, and fractionation and immunoblotting for GLUT1 and GLUT3
were performed, as described in Fig. 1. (B) A similar experiment was performed with CGL1/Glut3, which overproduce GLUT3 in non-tumorigenic CGL1
cells. (C) The DRM-distribution of GLUT1 in different cell types was also examined in HeLa-S3 cells and CHO-K1 cells solubilized by Triton X-100 (0.5% or
1%) at 4 jC. Fractionation and immunoblotting for GLUT1, caveolin-1 and a-tubulin were performed, as described in Fig. 1.
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protein concentration was determined using BCA reagent
(Pierce) with bovine serum albumin (BSA) as a standard.
Protein samples (5–10 Ag) were subjected to SDS-10%
PAGE, and transferred to immobilon-P membranes (Milli-
pore), which were incubated in TBS-Tween (500 mM NaCl,
20 mM Tris–HCl, pH 7.5, plus 0.1% Tween 20) containing
5% skim milk (Difco), followed by rabbit polyclonal anti-
body or mouse monoclonal antibody (1:1000–2000). The
membranes were further incubated with HRP-conjugated
anti-rabbit or anti-mouse IgG secondary antibody (Amer-
sham Pharmacia Biotech), and visualized with the ECL-
detection kit.
2.4. Detergent solubilization
The cells growing in two 10-cm dishes (HeLa-S3 and
HeLa cell hybrids, about 1107 cells/dish; CHO-K1, about
5 106 cells/dish) were washed twice with cold PBS, and
treated with 0.5 ml of Hepes buffer containing 1–0.5%
Triton X-100 (Sigma), 10 mM sodium Hepes, 150 mM
NaCl, 5 mM EDTA and 0.5 mM PMSF for 30 min at 4 jC
with gentle shaking. Alternatively, the cells which had been
washed and collected in a 1.5 ml tube were similarly
solubilized by Triton X-100 at 4 jC. The treated cells (about
1–2 107 cells) were mixed and an aliquot was kept as the
total fraction (T). The remainder were centrifuged at 13,000
rpm (12,000 g) for 30 min at 4 jC and the supernatant
was used as the soluble fraction (S). The pellet was washed
in 1 ml of cold Hepes buffer without detergent and was
centrifuged at 13,000 rpm for 10 min at 4 jC. This washing
procedure was repeated. The pellet (insoluble fraction, I)
was solubilized with 0.2–0.5 ml of lysis buffer. A similar
solubilization was performed with non-ionic detergent
Lubrol WX (Lubrol 17A17; Serva). The protein concen-
trations were determined as described above. As a control
experiment, solubilization at 37 jC instead of 4 jC was
performed.
2.5. Flotation assays
Detergent-insoluble complexes were analyzed by a flo-
tation method with Nycodenz, as described previously [30].
Briefly, confluent CGL4 cells growing in two 10-cm dishes
(about 2 107 cells) were collected in a tube and incubated
with 450 Al of MN buffer (25 mM MES, pH 6.5, and 150
mM NaCl) supplemented with protease inhibitors (GIBCO-
BRL) and either 1% or 0.5% TX-100 for 15 min at 4 jC.
Whole lysate was then adjusted to 35% with ice-cold 70%
Nycodenz prepared in MN buffer and loaded at the bottom
of ultracentrifuge tubes (Beckman TLS-55). An 8–35%
Nycodenz linear step gradient in MN buffer was overlaid
on the lysate (200 Al each of 25%, 22.5%, 20%, 18%, 15%,
12%, and 8% Nycodenz in MN buffer) and tubes were spun
at 55,000 rpm (200,000 g) for 4 h at 4 jC in a swing rotor.
Twelve fractions of 180 Al each were collected from the top
of the tube, from which 25 Al each was reserved for analyses
on protein determination and cholera-toxin binding. Proteins
in each fraction were then precipitated with 1 ml of
methanol and dissolved in either 50 Al (fractions 1–10) or
100 Al (fractions 11–12) of 2 sample buffer, subjected to
SDS-PAGE analysis and immunoblotted with 5 Al of each
fraction.
2.6. Detection of GM1 by cholera-toxin binding
As described in Ref. [30], 5 Al of whole lysate or each
fractionated sample was diluted with 0.5 ml of MN buffer
and 50 Al of each diluent was spotted onto an immobilon-P
membrane. After being washed with MN buffer, the mem-
brane was pre-incubated in 5% blocking solution (Blockace,
Dainippon Pharm. Co., Osaka, Japan) for 1 h at room
temperature, before being incubated with HRP-conjugated
cholera toxin B subunit (CTXB-HRP) at 1:1000 in TBS-
Tween containing 50% Blockace in MN buffer for 1 h. The
membrane was washed three times with TBS-Tween, and
visualization achieved with the ECL-detection kit, as
described above.
2.7. Depletion of membrane cholesterol
CGL4 cells grown in 3 cm dishes were pre-labeled with
[3H]cholesterol (0.25 ACi/ml) in 0.5% FCS-containing
DMEM for 20 h at 37 jC in 5% CO2, as described by
Fukasawa et al. [31]. After washing the cells with PBS, the
labeled cells were incubated for 30 min at 37 jC in 5% CO2
with 2 ml of serum-free DMEM in the presence of the
indicated concentrations of methyl-h-cyclodextrin (mhCD)
(Sigma). The amount of [3H]cholesterol incorporated into
the treated cells was determined by scintillation counting
after extraction by the method of Bligh and Dyer [32], and is
Fig. 3. Solubilization of membrane proteins by Lubrol WX. CGL4/Glut3
cells were solubilized by 1% or 0.5% non-ionic detergent Lubrol WX at
4 jC. Total cell lysate (T) was fractionated into soluble (S) and insoluble (I)
fractions, and each sample (10 Ag protein/lane) was subjected to SDS-PAGE
and immunoblotting, as indicated.
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expressed in cpm/dish. A similar cholesterol-depletion by
mhCD was performed with CGL4 cells or CGL4/Glut3
cells grown in 10 cm dishes, and solubilization by Triton X-
100, followed by fractionation and immunoblotting as
described above.
2.8. Immunofluorescence analysis by confocal microscopy
CGL4/Glut3 cells were grown on glass cover-slips. Cells
were fixed and permeabilized with 3.7% formaldehyde in
PBS containing 0.2% Triton X-100 for 10 min at room
Fig. 4. Flotation assay for solubilized proteins. CGL4 cells were solubilized by 0.5% or 1% Triton X-100 at 4 jC and total cell lysate (T) was subjected to
Nycodenz density gradient centrifugation. Each tube was fractionated into 12 samples, and an aliquot of each fraction was subjected to protein determination
(A) or SDS-PAGE analysis and staining (B). In (C), each diluent was blotted onto a nylon membrane and the distribution of GM1 was determined from the
binding of CTXB. In a separate experiment, an aliquot as determined in (B), was separated by SDS-PAGE, and immunoblottings for the indicated proteins were
performed. A single blotting membrane was used for the repeated probing. One result representative of at least three different determinations is shown here.
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temperature. After the blocking of non-specific binding sites
with staining buffer (PBS containing 0.1% BSA) for 10 min,
samples were treated with anti-GLUT1 or anti-GLUT3
together with anti-Annexin II antibody (BD Transduction
Lab) in staining buffer for 1 h, followed by incubation with
Alexa 488 or Alexa 594 secondary antibodies (Molecular
Probes) for 1 h at room temperature. The cells were washed
three times with PBS and mounted on glass slides with 80%
glycerol. In all cases, cells were visualized by confocal laser
scanning microscopy (Zeiss LSM 510). For the evaluation
of two-color experiments, digital images were overlaid
electronically and processed with PHOTOSHOP (Adobe).
3. Results
3.1. Differential solubilization of GLUT1 and GLUT3 by
Triton X-100
To compare the solubility of GLUT1 and GLUT3 in
non-ionic detergents, tumorigenic HeLa-derived hybrid
cells, CGL4, were treated with either 0.5% or 1% Triton
X-100 at 4 jC, and the solubilized (S) and insoluble (I)
fractions were separated by centrifugation at 12,000 g.
This procedure yielded more than 80% of total protein
(T) as the soluble fraction, which was stained by Coo-
massie brilliant blue (CBB), as shown in Fig. 1A. As
little as 10% of total protein was isolated as the insoluble
fraction, whose Coomassie-staining pattern was distinctive
from that of the soluble fraction, as indicated by several
arrows. These CBB-staining profiles of the detergent-
insoluble fractions were nearly identical when the cells
were solubilized by either 1% or 0.5% Triton X-100.
Immunoblotting of these samples indicated that IAP,
which is expressed in CGL4 cells but not in non-tumori-
genic CGL1 cells [28,29], was exclusively present in the
0.5% Triton X-100-insoluble fraction (Fig. 1B). Similarly,
caveolin-1, which is a major component of the caveolae
structure and well-known as a detergent-insoluble compo-
nent [21–26], was also abundant in this insoluble fraction,
although expression of caveolin-1 was reduced in CGL4
Fig. 5. Effect of increased temperature on detergent solubilization. CGL4
cells were solubilized by 0.5% Triton X-100 for 30 min at either 4 jC or
37 jC. Total cell lysate (T) was similarly fractionated into soluble (S) and
insoluble (I) fractions, and each sample (10 Ag protein/lane) was subjected
to SDS-PAGE and immunoblotting, as described in Fig. 1.
Fig. 6. Effect of cholesterol depletion on solubilization by Triton X-100.
(A) CGL4 cells, which had been pre-labeled with [3H]cholesterol, were
treated with the indicated concentrations of mhCD at 37 jC for 30 min, and
changes in [3H]cholesterol were analyzed. After a similar treatment with
mhCD, CGL4 cells (B) or CGL4/Glut3 cells (C) were solubilized by Triton
X-100 (0.5% or 1%) at 4 jC, and the fractionation and immunoblotting of
each fraction were performed, as indicated. In (D), 25 mM mhCD-treated
or untreated CGL4 cells were solubilized by 0.5% Triton X-100 at 4 jC, the
cell lysate was subjected to Nycodenz density gradient centrifugation, and
the distribution of GM1 and immunoblotting for GLUT1 and caveolin-1
were determined.
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cells compared to tumor-suppressed CGL1 cells [29]. Next,
we examined the distribution of GLUT1 and GLUT3.
GLUT3 was fully solubilized by 0.5% Triton X-100 at 4
jC (Fig. 1B). In contrast, GLUT1 remained in the insoluble
fraction, although it was also distributed in the soluble
fraction.
3.2. Differential solubility of GLUT1 and GLUT3 in non-
ionic detergents in transfectants which overproduce GLUT3
or GLUT1
To examine whether the difference in the distribution of
these isoforms to the detergent-soluble or insoluble fraction
is due to quantitative differences in the cells, a similar
solubilization procedure was performed with transfectants
which stably overproduced either GLUT3 or GLUT1 in
HeLa cell hybrids. In GLUT3-transfected CGL4 cells,
CGL4/Glut3, the overproduced GLUT3 was entirely solu-
bilized by 0.5% Triton X-100 at 4 jC without an effect on
the distribution of GLUT1, caveolin-1 and IAP in the
insoluble fraction (Fig. 2A). Similar results were obtained
with solubilization by 1% Triton X-100, although the
proportion of GLUT1 associated with DRM was reduced.
The overexpressed GLUT1 in CGL4 cells was similarly
distributed to both fractions, as seen with parental CGL4
cells (data not shown). In any case, a-tubulin was fully
solubilized under these conditions, as a positive marker for
solubilization.
The differential solubility of GLUT1 and GLUT3 was
further examined in different types of cells. Since a tumor-
suppressed HeLa cell hybrid, CGL1, expresses GLUT1
alone, an experiment was performed with GLUT3-trans-
fected CGL1 cells (CGL1/Glut3). In this transfectant,
GLUT1 was similarly retained in the insoluble fraction
Fig. 6 (continued).
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when it was treated with 0.5% Triton X-100 at 4 jC, while
the overproduced GLUT3 was fully solubilized by this
detergent (Fig. 2B). Thus, the differential distribution of
GLUT1 and GLUT3 to DRMs seems to be independent of a
tumorigenic or N-glycosylated state, since N-glycosylation
of both GLUT1 and GLUT3 in tumorigenic CGL4 cells was
modulated to larger forms [11–13].
A similar resistance of GLUT1 to cold Triton X-100 was
observed in HeLa-S3 cells and Chinese hamster ovary
(CHO-K1) cells (Fig. 2C), in which a-tubulin was fully
solubilized, although the highly expressed caveolin-1 in
CHO cells was partly solubilized. The insoluble nature of
GLUT1 but not GLUT3 was also evident when CGL4/Glut3
cells were treated with another non-ionic detergent, Lubrol
WX, whose hydrophilic–lipophilic balance (HLB) is greater
than that of Triton X-100 (Fig. 3). In this experiment, a-
tubulin was fully solubilized, while caveolin-1 was retained
in the insoluble fraction.
3.3. Flotation profiles of solubilized membrane proteins
To examine the detergent-resistant nature of GLUT1
based on its distribution to a raft-like lipid domain, whole
cell lysates solubilized by Triton X-100 at 4 jC were
centrifuged on a density gradient. By this procedure, fully
solubilized proteins as well as cytosolic proteins remain in
the bottom layer in which the sample is loaded, whereas
insoluble proteins in lipid-rich vesicles or DRM domains
float on the upper layer [23–26].
Whole CGL4 cell lysates, solubilized by either 0.5% or
1% Triton X-100 at 4 jC, were centrifuged with a step
gradient of 5–35% Nycodenz, and fractionated to 12
tubes. As shown in Fig. 4A, most soluble proteins were
recovered from fractions 8 to 12. Consistent with this,
proteins in these fractions were heavily stained with CBB
after separation by SDS-PAGE (Fig. 4B). Although few
proteins were detected by CBB-staining in the lower
density fractions, a flotation marker for the lipid-rich ve-
sicles, ganglioside GM1, which was detected by CTXB-
binding, broadly floated to the upper fractions between 2
and 6 in both samples (Fig. 4C). A DRM-associated
protein, IAP, also floated up to these fractions, around 2
to 6. In addition, Caveolin-1 floated in the upper fractions,
but was distributed more widely than IAP. Most GLUT1
was co-distributed with IAP in the upper fractions when
cells were solubilized by 0.5% Triton X-100, but it was
more widely distributed to the lower fractions when
solubilized by 1% Triton X-100. In contrast, GLUT3
was mostly distributed in the bottom layers, between 7
and 10, containing the transferrin receptor (TfR), clathrin
heavy chain (HC) and a-tubulin. The differential flotation
profiles between GLUT1 and GLUT3 were reproduced in
transfectants which overproduce either GLUT3 or GLUT1
(data not shown). These flotation assays further support
that GLUT1 but not GLUT3 distributes to the DRM or
raft-like lipid domains.
3.4. Increased temperature of solubilization
In all of the experiments described above, solubilization
was performed at 4 jC. Since phase partitioning by lipids
shows a strong temperature dependence [21], we also
solubilized membranes at 37 jC to increase stringency.
The disappearance of GLUT1 from the Triton X-100-
insoluble fraction was evident on solubilization of CGL4
cells at 37 jC (Fig. 5). A small amount of IAP was also
solubilized at 37 jC, but most IAP remained in the insoluble
fraction. However, the solubility of caveolin-1 in Triton X-
100 was unaffected by the increased temperature, suggest-
ing that among these membrane proteins, caveolin-1 is
most tightly associated with the DRM domain(s) in CGL4
cells.
3.5. Effect of cholesterol depletion on solubilization
Since one of the major components of the detergent-
resistant lipid domains, DRM or rafts, is cholesterol [21–
24], it would be important to examine whether depletion of
cholesterol affects solubilization of DRM-associated
GLUT1 by Triton X-100. For this purpose, the depletion
of cholesterol by mhCD was monitored by the decrease in
the amount of [3H]cholesterol from the labeled cells, as
described by Fukasawa et al. [31]. A marked depletion of
[3H]cholesterol was induced by mhCD during incubation
with CGL4 cells for 30 min at 37 jC in a dose-dependent
manner, and more than 60% of total cholesterol was
depleted by 10–25 mM mhCD (Fig. 6A). Accordingly,
GLUT1, which had remained in the insoluble fraction in
0.5% Triton X-100, was rendered soluble in the cholesterol-
depleted cells (Fig. 6B). In contrast, even though cholesterol
depletion by mhCD was maximal, the IAP solubilized by
Triton X-100 was minimal, and the insolubility of caveolin-
1 was nearly unaffected. The increased solubility of GLUT1
in cold Triton X-100, which was dependent upon choles-
terol depletion, was similarly observed in CGL4/Glut3 cells,
in which solubilization of GLUT3 as well as a-tubulin was
unaffected by the treatment with mhCD (Fig. 6C), indicat-
ing that the non-ionic detergent-resistant nature of GLUT1
is reduced by cholesterol depletion.
Flotation profiles for GLUT1 on density gradient cen-
trifugation of mhCD-treated cells revealed a broad shift to
the lower fractions without an effect on the distribution of
caveolin-1 and IAP (Fig. 6D).
3.6. Immunofluorescence analysis of the membrane distri-
bution of glucose transporters by confocal laser scanning
microscopy
To determine if there is any difference in the distribution
of GLUT1 and GLUT3 in living cells, immunofluorescence
analyses were performed with a confocal laser scanning
microscope. When CGL4/Glut3 cells, which were fixed and
permeabilized at room temperature (20–24 jC), were
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stained with either anti-GLUT1 or GLUT3 antibody and an
immunofluorescent-secondary antibody, both isoforms were
detected along with the plasma membranes. However, the
digital images for GLUT1 and GLUT3 seemed to be
distinctive especially at the edge regions of the cells (Fig.
7). When each image was merged with that of anti-Annexin
II, which is a calcium/phospholipid-binding protein [33] and
was entirely distributed on the membrane, the preferential
distribution of GLUT1 to the edge regions was found to be
remarkable in these cells.
4. Discussion
It has been documented that microdomains, such as
DRMs or lipid rafts, exist in the plasma membrane of
various types of living cells [21–26]. In certain cells, small
invaginations of the membrane, caveolae whose major
component is caveolin, with a detergent-resistant phenotype
are also identified. Due to the ordered nature of these
microdomains, isolation with non-ionic detergents is com-
monly used, although more sophisticated procedures with-
out detergents have recently been developed [26,27]. DRM-
or raft-associated proteins, such as GPI-anchored proteins,
Src-kinases and Ras, are organized into this lipid bilayer
either through their GPI moieties or covalently linked acyl
chains. The association with the DRM of caveolin, which is
not anchored by GPI, does not require acylation [34].
In the present paper, we described that the distribution of
glucose transporter isoforms GLUT1 and GLUT3 in the
plasma membranes of non-polarized cells seems to be differ-
ent. In HeLa cell lines and CHO cells, GLUT1 is distributed
to detergent-resistant raft-like domains (DRM), whereas
GLUT3 is preferentially distributed in fluid lipid domains.
This interpretation is based upon the following results: first,
GLUT3 was fully solubilized by cold non-ionic detergents,
such as Triton X-100 and Lubrol WX, whereas GLUT1
remained in the insoluble fractions together with DRM-
associated proteins, such as caveolin-1 and IAP (Figs. 1–
3). Second, this insolubility of GLUT1 in Triton X-100 was
reduced by cholesterol depletion (Fig. 6), which may control
the liquid-ordered state of DRM [21–24]. Third, GLUT1
floated up to the lower density fraction containing caveolin-
1, IAP and the ganglioside GM1 on density gradient cen-
trifugation of cell lysates, whereas GLUT3 remained in the
bottom layers together with most solubilized proteins includ-
ing TfR and a-tubulin (Fig. 4). Finally, the differential
distribution of glucose transporter isoforms in membrane
domains might be due to intrinsic properties, since over-
production or N-glycosylation state did not affect the dis-
tribution, and it was seen in other cell types or tumor-
suppressed hybrid cells (Figs. 2 and 3). Immunofluorescence
Fig. 7. Immunofluorescence detection of glucose transporters in HeLa cell lines. CGL4/Glut3 cells were fixed and permeabilized at room temperature. After
staining of the cells with anti-GLUT1 or anti-GLUT3 antibody (rabbit) together with anti-annexin II antibody (mouse), followed by incubation with Alexa 488-
conjugated anti-rabbit IgG or Alexa 594-conjugated anti-mouse IgG antibody, the immunofluorescence was visualized by confocal laser scanning microscopy
and the two-color digital images were overlaid and processed.
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analysis by confocal laser scanning microscopy supports a
distinctive localization of these isoforms on the living cell
surface, although the linkage to the DRM structure remains
unknown.
The membrane organization of DRMs or rafts would
be regulated by a selective TGN-dependent trafficking of
membrane components [25]. A well-defined example is
the apical sorting of GPI-proteins and glycolipids to DRM
domains in polarized epithelial cells. A similar TGN-
dependent pathway to DRM domains may exist in non-
polarized cells [25]. It seems contradictory, however, that
GLUT3, appearing on the apical surface, was sensitive to
detergent but GLUT1, sorted to the basolateral surface,
was associated with the DRM. Although N-glycan is
proposed as one of the apical sorting signals in polarized
cells [25], the N-glycosylation state of the glucose trans-
porters might not be critical to the differential distribution
to the membrane domains in non-polarized cells. These
observations would lead one to ask if there is some com-
mon element(s) or signal(s) for the sorting and distribu-
tion of these glucose transporters to the microdomains of
membranes. More recently, a distribution to the DRM
domains has been reported for P-glycoprotein [35,36], a
multiple membrane-spanning protein, which mediates an
ATP-dependent efflux of chemotherapeutic agents. Since
no functional amino acid sequence for GPI-anchoring or
the acylation of P-glycoprotein or GLUT1 has been
noted, these N-glycoproteins containing 12 membrane-
spanning segments may be distributed to the DRM
through hydrophobic interactions with a liquid-ordered
lipid phase.
Among DRMs or lipid rafts, there are distinctive micro-
domains, that would be regulated, at least in part, by
membrane cholesterol [21–24]. On the neuronal surface,
different GPI proteins, such as Thy-1 and prion protein
(PrP), are distributed to different DRM domains [37]. Thy-1
localizes in a cholesterol/sphingolipid-rich ordered domain,
while PrP is present in a semi-ordered lipid domain. An
apical membrane protein, prominin, also exists in a distinct
DRM in microvilli of epithelial cells, which is based on
cholesterol content [38]. Prominin is well solubilized by
cold Triton X-100, but is resistant to Lubrol WX probably
due to its greater HLB than Triton X-100. In the present
study, the insolubility of GLUT1 was greater in Lubrol WX
than in Triton X-100 (Figs. 1 and 3). Under these condi-
tions, caveolin-1 and IAP were insoluble, but the insolubil-
ity of these proteins in detergent was affected differently by
temperature and cholesterol. GLUT1 was rendered soluble
by increased temperature (Fig. 5) or the depletion of
cholesterol (Fig. 6). In contrast, little increase in the sol-
ubility of caveolin-1 and IAP was caused by these treat-
ments. These results suggest that these proteins are localized
in highly ordered DRM domains, whereas GLUT1 is
organized in a cholesterol-rich, but less-ordered lipid
domain. In contrast, GLUT3 and TfR may exist in more
fluid membrane domains.
However, a major concern about the physiological rele-
vance of the present findings is that at the physiological
temperature (37 jC) GLUT1 was extractable with Triton X-
100 (Fig. 5). The increased solubility by non-ionic deter-
gents at higher temperature is one of the well characterized
features of raft-associated proteins and is ascribed to a
decrease in the ordered phase of the lipid bilayer, as
described for cholesterol depletion [21–24,26]. These cri-
teria are fundamentally supported by a possible raft associ-
ation of GLUT1, as described above. Evidence has also
emerged that raft-associated proteins with a detergent-resist-
ant nature are distributed to cholesterol-rich microdomains
under physiological conditions [26,27]. It remains possible
that the present characteristics of GLUT1 and GLUT3 are
artifacts of the preparation of DRM. In line with this, we
used an alternative method to isolate raft-like membranes
with detergent-free medium containing a high concentration
of sodium carbonate. As previously described [39], caveo-
lin-rich membrane fractions were separated from most
cellular proteins such as a-tubulin and annexin II by density
gradient centrifugation. GLUT1 was retained in this cav-
eolin-rich fraction, but it was inseparable from GLUT3
under the conditions (data not shown). The physiological
relevance of the association of GLUT1 with the DRM must
await further experimentation, clarifying the discrepancy
over membrane components due to different procedures.
With this respect, an alternative mention of the present
study may well be linked to the membrane localization of
both isoforms described in polarized cells such as Caco-2
and MDCK cells, in which GLUT1 is at the basolateral
surface, whereas GLUT3 is at the apical surface [17,18]. It
is possible that at 4 jC, GLUT1 becomes associated with
the DRM area probably due to biophysical interactions of
membrane lipids and proteins. One interpretation is that
these changes may be induced at the basolateral membrane,
while not occurring in the apical membrane. Such a differ-
ence in the physicochemical nature of the polarized mem-
branes or DRM domains may cause the difference in
distribution and solubility at low temperature of these iso-
forms. These characteristics may partly explain distinctive
localization of these isoforms, as revealed by immunofluor-
escence confocal microscopy. Future studies on the molec-
ular mechanisms that control the localization and function of
glucose transporters in DRM or non-DRM domains should
clarify sorting signals and distinctive roles for these proteins
in mammalian cells.
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